BioMerieux SA (XPAR:BIM)
€ 99.3 0.05 (0.05%) Market Cap: 11.73 Bil Enterprise Value: 11.90 Bil PE Ratio: 32.99 PB Ratio: 3.13 GF Score: 98/100

Full Year 2021 Biomerieux SA Earnings Call Transcript

Mar 02, 2022 / 01:30PM GMT
Release Date Price: €87.56 (-8.68%)
Operator

Good day, and welcome to the bioMerieux Full Year 2021 Financial Results. Today's call is being recorded. At this time, I would like to turn the conference over to Franck Admant. Please go ahead.

Franck Admant;rieux S.A.;Director of IR
bioMÃ

©-

Thank you. Good day, everyone, and thank you for joining us to review bioMerieux performance for 2021 and our objective for 2022. Before leaving the floor to Alexandre Merieux, Chairman and CEO; and Guillaume Bouhours, CFO, I will just make a very short introduction to provide you with a couple of information. First of all, our press release was published this morning at 7 a.m. You can find it on the home page of our website.

In addition, note that the slide of this meeting will be available also on the home page, and you can download it shortly after the webcast. From here to the end of the meeting, the webcast and the call will be available in replay on our website.

Now going to the presentation contains after reviewing our 2021 performance and 2022 objectives, where

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot